Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1031"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"evidence_1185"
|
| rdf:type | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_type | |
| ?:content |
"The FDA recommends this as an acceptable chemical CYP2D6 substrate (CYP2D6-->(debrisoquin->4-hydroxydebrisoquin)) for in vitro experiments in it most recent guidance document. See Table 3, p. 32"
|
| dc:creator | |
| dc:date |
"05/06/2009 11:02:57"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ debrisoquine_in_vitro_probe_substrate_of_enzyme_cyp2d6, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1185 }